Pages that link to "Q53128282"

The following pages link to Rossella Bertulli (Q53128282):

Displaying 27 items.

• Imatinib mesylate in chordoma (Q28282621) (← links)
• Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma. (Q33371397) (← links)
• Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial. (Q33419286) (← links)
• A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors (Q33817421) (← links)
• A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient (Q34331384) (← links)
• Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. (Q34532365) (← links)
• Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution (Q34549587) (← links)
• Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial (Q34551403) (← links)
• Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. (Q34638074) (← links)
• Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution (Q35184350) (← links)
• Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma. (Q39669916) (← links)
• Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma (Q40590667) (← links)
• Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma (Q41008543) (← links)
• Unusual sites of Ewing sarcoma (ES): a retrospective multicenter 30-year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) and Italian Sarcoma Group (ISG). (Q44778671) (← links)
• Epithelioid sarcoma: prognostic factors and survival in a series of patients treated at a single institution (Q44830728) (← links)
• Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. (Q45257998) (← links)
• Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs). (Q46273752) (← links)
• Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial (Q46658501) (← links)
• Rapid-onset opioids for the treatment of breakthrough cancer pain: two cases of drug abuse. (Q47851937) (← links)
• High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria (Q51849514) (← links)
• Primary Ewing's sarcoma of the sinonasal tract in adults: A challenging disease. (Q52952634) (← links)
• At the crossroads of molecular biology, pathology and the clinic (Q53128219) (← links)
• c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors. (Q53559201) (← links)
• Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion. (Q54084719) (← links)
• Cytokeratin Immunoreactivity in 41 Cases of ES/PNET Confirmed by Molecular Diagnostic Studies (Q59287294) (← links)
• Prognostic Effect of Re-Excision in Adult Soft Tissue Sarcoma of the Extremity (Q61623001) (← links)
• Status of Surgical Margins and Prognosis in Adult Soft Tissue Sarcomas of the Extremities: A Series of Patients Treated at a Single Institution (Q61623008) (← links)